Two years after securing strategic investment from Danish pharmaceutical company Lundbeck, a biopharma startup is collaborating with the company on a drug delivery platform for pain relief and central nervous system disorders. Ossianix’s single domain antibody platform takes its inspiration from a shark model. The first project will advance its antibody platform to treat pain, […]
Ossianix, an early stage biopharmaceutical startup that utilizes shark antibodies as a model for drugs to treat central nervous system disorders, has received a strategic investment from Danish pharmaceutical company H Lundbeck. The investment amount was not disclosed, but Dr. Frank Walsh, cofounder and CEO of Ossianix, said it would be enough to fund the […]
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.